The latest closing stock price for Rapport Therapeutics as of July 21, 2025 is 14.39.
An investor who bought $1,000 worth of Rapport Therapeutics stock at the IPO in 2024 would have $-308 today, roughly 0 times their original investment - a -30.82% compound annual growth rate over 1 years.
The all-time high Rapport Therapeutics stock closing price was 29.23 on October 16, 2024.
The Rapport Therapeutics 52-week high stock price is 29.74, which is 106.7% above the current share price.
The Rapport Therapeutics 52-week low stock price is 6.43, which is 55.3% below the current share price.
The average Rapport Therapeutics stock price for the last 52 weeks is 16.28.
An investor who bought $1,000 worth of Rapport Therapeutics stock at the IPO in 2024 would have $-308 today, roughly 0 times their original investment - a -30.82% compound annual growth rate over 1 years.
The all-time high Rapport Therapeutics stock closing price was 29.23 on October 16, 2024.
The Rapport Therapeutics 52-week high stock price is 29.74, which is 106.7% above the current share price.
The Rapport Therapeutics 52-week low stock price is 6.43, which is 55.3% below the current share price.
The average Rapport Therapeutics stock price for the last 52 weeks is 16.28.